Name: Influenza Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMPH1525
Price: 4350 USD
Availability: InStock

Influenza Therapeutics Market Size Share Growth Opportunities and Forecast 2022

Influenza Therapeutics Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Influenza Therapeutics Market is segmented&nbsp;By Therapy Type(Vaccines,&nbsp;Antiviral Drugs), By End User (Hospital Pharmacies,&nbsp;Retail Pharmacies, Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global Influenza Therapeutics Market is expected to grow at a high <a href="https://www.datamintelligence.com/download-sample/influenza-therapeutics-market">CAGR&nbsp;of 7.2%</a> during the forecasting period (2022-2029).
</blockquote>

<h2>Why purchase the report?</h2>

<ul>
	<li>
	Visualize the composition of the Influenza Therapeutics Market across each indication, regarding type and application highlighting the critical commercial assets and players.
	</li>
	<li>
	Identify business opportunities in Influenza Therapeutics Market by analyzing trends and co-development deals.
	</li>
	<li>
	Excel data sheet with thousands of data points of the Influenza Therapeutics Market levels 4/5 segmentation.
	</li>
	<li>
	PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
	</li>
	<li>
	Product mapping in excel for the essential Meningitis Vaccines Market of all major market players.
	</li>
</ul>

<h2>Who can benefit from this report?</h2>

<ul>
	<li>
	Raw Material Suppliers/ Buyers
	</li>
	<li>
	Product Suppliers/ Buyers
	</li>
	<li>
	Industry Investors/Investment Bankers
	</li>
	<li>
	<a href="https://www.datamintelligence.com/enquiry/influenza-therapeutics-market">Education &amp; Research Institutes</a>
	</li>
	<li>
	Research Professionals
	</li>
	<li>
	Emerging Companies
	</li>
	<li>
	Manufacturers
	</li>
</ul>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics:</h3>

<a href="https://www.datamintelligence.com/research-report/biological-multiplex-assays-market">Biological Multiplex Assays Market</a>

<a href="https://www.datamintelligence.com/research-report/optical-disorders-drugs-market">Optical Disorders Drugs Market</a>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>
		Market Snippet by Therapy Type
		</li>
		<li>
		Market Snippet by End User
		</li>
		<li>
		Market Snippet by Region
		</li>
		<li>
		DataM CLO Scenario
		</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Rise in prevalence of influenza
				</li>
				<li>
				Growth in geriatric population
				</li>
				<li>
				Increase in government funding
				</li>
			</ol>
			</li>
			<li>
			Restraints

			<ol>
				<li>
				Low healthcare awareness
				</li>
			</ol>
			</li>
			<li>
			Opportunity
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis&nbsp;</h3>

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Epidemiology
		</li>
	</ol>
	</li>
	<li>
	<h3>Pipeline Analysis&nbsp;</h3>
	</li>
	<li>
	<h3>By Therapy Type</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
			</li>
			<li>
			&nbsp;Market Attractiveness Index, By Therapy Type
			</li>
		</ol>
		</li>
		<li>
		Vaccines

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%)
			</li>
			<li>
			Trivalent
			</li>
			<li>
			Quadrivalent
			</li>
		</ol>
		</li>
		<li>
		&nbsp;Antiviral Drugs

		<ol>
			<li>
			&nbsp;Zanamivir
			</li>
			<li>
			&nbsp;Oseltamivir
			</li>
			<li>
			&nbsp;Peramivir
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>By End User</h3>

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User&nbsp;
			</li>
			<li>
			Market Attractiveness Index, By End User
			</li>
		</ol>
		</li>
		<li>
		Hospital Pharmacies

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
			</li>
		</ol>
		</li>
		<li>
		&nbsp;Retail Pharmacies
		</li>
		<li>
		&nbsp;Online Pharmacies
		</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>
		Introduction&nbsp;

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia-Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		The Middle East and Africa
		</li>
		<li>
		Introduction
		</li>
		<li>
		Key Region-Specific Dynamics
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Type
		</li>
		<li>
		Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
		</li>
	</ol>
	</li>
	<li>
	<h3>Global Market Competitive Landscape</h3>

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Competitor Influenza Therapeutics Strategy Analysis
		</li>
		<li>
		Comparative Product Portfolio Analysis
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	<h3>Global Market Company Profiles</h3>

	<ol>
		<li>
		Abbott Laboratories Limited *

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		Astrazeneca Plc
		</li>
		<li>
		Biocryst Pharmaceuticals Inc.
		</li>
		<li>
		CSL Limited
		</li>
		<li>
		Daiichi Sankyo Co. Ltd.
		</li>
		<li>
		GlaxoSmithKline Plc
		</li>
		<li>
		Mitsubishi Tanabe Pharma Corporation
		</li>
		<li>
		Nanotherapeutics Inc.
		</li>
		<li>
		Protein Sciences Corporation
		</li>
		<li>
		Roche Holding AG
		</li>
		<li>
		Sanofi SA
		</li>
		<li>
		Shionogi &amp; Co. Ltd.
		</li>
		<li>
		Sinovac Biotech Ltd.
		</li>
		<li>
		Luminex Corporation
		</li>
		<li>
		Mylan N.V.
		</li>
		<li>
		Orasure Technologies Inc.
		</li>
		<li>
		Quidel Corporation
		</li>
		<li>
		Seqirus GmbH
		</li>
		<li>
		Novartis AG
		</li>
	</ol>
	</li>
	<li>
	<h3>Premium Insights</h3>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables and Figures</h2>

List of Tables

Table 1 Global Influenza Therapeutics Market Value, By Therapy Type, 2021,2025 &amp; 2029 ($ Million)

Table 2 Global Influenza Therapeutics Market Value, By End User, 2021,2025 &amp; 2029 ($ Million)

Table 3 Global Influenza Therapeutics Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 4 Global Influenza Therapeutics Market Value, By Therapy Type, 2021,2025 &amp; 2029 ($ Million)

Table 5 Global Influenza Therapeutics Market Value, By Therapy Type, 2017-2028 ($ Million)

Table 6 Global Influenza Therapeutics Market Value, By End User, 2021,2025 &amp; 2029 ($ Million)

Table 7 Global Influenza Therapeutics Market Value, By End User, 2017-2028 ($ Million)

Table 8 Global Influenza Therapeutics Market Value, By Region, 2021,2025 &amp; 2029 ($ Million)

Table 9 Global Influenza Therapeutics Market Value, By Region, 2017-2028 ($ Million)

Table 10 North America Influenza Therapeutics Market Value, By Therapy Type, 2017-2028 ($ Million)

Table 11 North America Influenza Therapeutics Market Value, By End User, 2017-2028 ($ Million)

Table 12 North America Influenza Therapeutics Market Value, By Country, 2017-2028 ($ Million)

Table 13 South America Influenza Therapeutics Market Value, By Therapy Type, 2017-2028 ($ Million)

Table 14 South America Influenza Therapeutics Market Value, By End User, 2017-2028 ($ Million)

Table 15 South America Influenza Therapeutics Market Value, By Country, 2017-2028 ($ Million)

Table 16 Europe Influenza Therapeutics Market Value, By Therapy Type, 2017-2028 ($ Million)

Table 17 Europe Influenza Therapeutics Market Value, By End User, 2017-2028 ($ Million)

Table 18 Europe Influenza Therapeutics Market Value, By Country, 2017-2028 ($ Million)

Table 19 Asia-Pacific Influenza Therapeutics Market Value, By Therapy Type, 2017-2028 ($ Million)

Table 20 Asia-Pacific Influenza Therapeutics Market Value, By End User, 2017-2028 ($ Million)

Table 21 Asia-Pacific Influenza Therapeutics Market Value, By Country, 2017-2028 ($ Million)

Table 22 Middle East &amp; Africa Influenza Therapeutics Market Value, By Therapy Type, 2017-2028 ($ Million)

Table 23 Middle East &amp; Africa Influenza Therapeutics Market Value, By End User, 2017-2028 ($ Million)

Table 24 Abbott Laboratories Limited: Overview

Table 25 Abbott Laboratories Limited: Product Portfolio

Table 26 Abbott Laboratories Limited: Key Developments

Table 27 Astrazeneca Plc: Overview

Table 28 Astrazeneca Plc: Product Portfolio

Table 29 Astrazeneca Plc: Key Developments

Table 30 Biocryst Pharmaceuticals Inc.: Overview

Table 31 Biocryst Pharmaceuticals Inc.: Product Portfolio

Table 32 Biocryst Pharmaceuticals Inc.: Key Developments

Table 33 CSL Limited: Overview

Table 34 CSL Limited: Product Portfolio

Table 35 CSL Limited: Key Developments

Table 36 Daiichi Sankyo Co. Ltd: Overview

Table 37 Daiichi Sankyo Co. Ltd: Product Portfolio

Table 38 Daiichi Sankyo Co. Ltd: Key Developments

Table 39 GlaxoSmithKline Plc: Overview

Table 40 GlaxoSmithKline Plc: Product Portfolio

Table 41 GlaxoSmithKline Plc: Key Developments

Table 42 Mitsubishi Tanabe Pharma Corporation: Overview

Table 43 Mitsubishi Tanabe Pharma Corporation: Product Portfolio

Table 44 Mitsubishi Tanabe Pharma Corporation: Key Developments

Table 45 Nanotherapeutics Inc.: Overview

Table 46 Nanotherapeutics Inc.: Product Portfolio

Table 47 Nanotherapeutics Inc.: Key Developments

Table 48 Protein Sciences Corporation: Overview

Table 49 Protein Sciences Corporation: Product Portfolio

Table 50 Protein Sciences Corporation: Key Developments

Table 51 Roche Holding AG: Overview

Table 52 Roche Holding AG: Product Portfolio

Table 53 Roche Holding AG: Key Developments

List of Figures

Figure 1 Global Influenza Therapeutics Market Share, By Therapy Type, 2018 &amp; 2028 (%)

Figure 2 Global Influenza Therapeutics Market Share, By End User, 2018 &amp; 2028 (%)

Figure 3 Global Influenza Therapeutics Market Share, By Region, 2018 &amp; 2028 (%)

Figure 4 Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 5 Global Influenza Therapeutics Market Y-o-Y Growth, By Therapy Type, 2018-2028 (%)

Figure 6 Vaccines: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 7 Antiviral Drugs: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 8 Trivalent: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 9 Quadrivalent: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 10 Zanamivir: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 11 Oseltamivir: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 12 Peramivir: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 13 Global Influenza Therapeutics Market Y-o-Y Growth, By End User, 2018-2028 (%)

Figure 14 Hospital Pharmacies: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 15 Retail Pharmacies: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 16 Online Pharmacies: Global Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 17 Global Influenza Therapeutics Market Y-o-Y Growth, By Region, 2018-2028 (%)

Figure 18 North America Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 19 North America Influenza Therapeutics Market Share, By Therapy Type, 2018 &amp; 2028 (%)

Figure 20 North America Influenza Therapeutics Market Share, By End User, 2018 &amp; 2028 (%)

Figure 21 North America Influenza Therapeutics Market Share, By Country, 2018 &amp; 2028 (%)

Figure 22 South America Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 23 South America Influenza Therapeutics Market Share, By Therapy Type, 2018 &amp; 2028 (%)

Figure 24 South America Influenza Therapeutics Market Share, By End User, 2018 &amp; 2028 (%)

Figure 25 South America Influenza Therapeutics Market Share, By Country, 2018 &amp; 2028 (%)

Figure 26 Europe Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 27 Europe Influenza Therapeutics Market Share, By Therapy Type, 2018 &amp; 2028 (%)

Figure 28 Europe Influenza Therapeutics Market Share, By End User, 2018 &amp; 2028 (%)

Figure 29 Europe Influenza Therapeutics Market Share, By Country, 2018 &amp; 2028 (%)

Figure 30 Asia-Pacific Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 31 Asia-Pacific Influenza Therapeutics Market Share, By Therapy Type, 2018 &amp; 2028 (%)

Figure 32 Asia-Pacific Influenza Therapeutics Market Share, By End User, 2018 &amp; 2028 (%)

Figure 33 Asia-Pacific Influenza Therapeutics Market Share, By Country, 2018 &amp; 2028 (%)

Figure 34 Middle East &amp; Africa Influenza Therapeutics Market Value, 2017-2028 ($ Million)

Figure 35 Middle East &amp; Africa Influenza Therapeutics Market Share, By Therapy Type, 2018 &amp; 2028 (%)

Figure 36 Middle East &amp; Africa Influenza Therapeutics Market Share, By End User, 2018 &amp; 2028 (%)

Figure 37 Abbott Laboratories Limited: Financials

Figure 38 Astrazeneca Plc: Financials

Figure 39 Biocryst Pharmaceuticals Inc.: Financials

Figure 40 CSL Limited: Financials

Figure 41 Daiichi Sankyo Co. Ltd: Financials

Figure 42 GlaxoSmithKline Plc: Financials

Figure 43 Mitsubishi Tanabe Pharma Corporation: Financials

Figure 44 Nanotherapeutics Inc.: Financials

Figure 45 Protein Sciences Corporation: Financials

Figure 46 Roche Holding AG: Financials